Zambia Pharma Manufacturing: Equipment & RFQ Guide

Pharmaceutical manufacturing equipment demand in Zambia centres on one project: the Akums plant under construction at Lusaka South MFEZ since October 2025, backed by a USD 50 million government medicine-purchase commitment and targeting commercial production in 2028. Around it sit a handful of licensed local producers upgrading their lines. This guide maps the equipment packages, the named buyers, and how they pay.

The equipment packages Zambia’s pharma build-out creates

The buying splits into four package families, and in Zambia the greenfield anchor defines all of them at once.

The Akums facility will produce tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products on roughly 40 acres, according to reporting from the October 2025 ground-breaking ceremony. That is every major dosage form on a single site, which is rare in the region. Each form pulls its own equipment tender rhythm.

Oral solid dose is the volume core. Granulation suites, compression, coating, and capsule filling carry the plant’s essential-medicines list, and the same machines sit on the upgrade lists of Zambia’s existing producers. Our guide to tablet press suppliers for Zambia covers what buyers in Lusaka specify at line level.

Sterile scope is the technical bar. An injectables block plus beta-lactam segregation means filling and stoppering machinery, autoclaves, water-for-injection loops, and isolator or RABS containment, bought against qualification documents rather than delivery notes. The injectable filling line guide for Zambia goes deeper on that scope.

The enabling package is contracted earliest and often separately: classified cleanroom HVAC, purified water generation, environmental monitoring, and effluent treatment. In a greenfield on this scale the HVAC and utilities contract can rival the process line in value. See our guide to cleanroom HVAC suppliers for Zambia for how that scope gets bought.

Packaging closes every line. Blister and strip machines, bottle filling, cartoning, and serialisation-ready labelling ride behind each dosage form, and existing producers buy this tier even in years when they buy nothing else. The Zambia blister packaging machine project guide maps that segment.

Medical devices remain import-supplied. Zambia has no device production base of note, so near-term device-side demand is laboratory equipment, cold-chain storage, and warehouse handling systems for the public distribution network rather than production machinery. Treat device manufacturing as a watch item, not a market.

Who signs equipment orders in Zambia

The buyer list is short, and one entry dwarfs the rest.

The Akums joint venture is the anchor. India’s Akums Drugs and Pharmaceuticals holds a 51 percent stake alongside the Zambian government, per PharmaSource’s coverage of the deal, and Zambia has committed to purchase a minimum of USD 50 million of medicines from Akums’ Indian facilities in 2026 and 2027, bridging supply until the Lusaka plant starts commercial manufacturing, expected in 2028. A committed offtake of that size is what lets the project buy equipment now, which is exactly why vendors should be talking to the project team during construction, not at commissioning.

The existing base is small but real. A 2022 regulatory review counted ten registered local producers, seven doing actual production, with the rest repackaging imports, per the Zambia Association of Manufacturers. The named plants to map: Pharmanova Zambia, running three Lusaka manufacturing sites, plus NRB Pharma, International Drug Company, and Yashi Life Sciences, the four manufacturers ZAMRA convened in its local-producer engagements. Their purchases are single machines and line extensions rather than plants, and GMP compliance pressure from ZAMRA inspections is what triggers them.

European interest has an institutional channel. The Zambian government’s Pharmaceutical Manufacturing Initiative is backed by the EU’s Team Europe MAV+ programme, and the first Zambia-EU Pharmaceutical Manufacturing Forum in March 2023 drew over 600 participants and produced an MoU between Pharmanova and Spain’s Fredlab, with German machinery firms Rommelag and Bdv Behrens in the room. That forum circuit is where European OEMs get introduced to Zambian principals with government blessing.

The offtake side shapes everything. The Zambia Medicines and Medical Supplies Agency (ZAMMSA) procures, warehouses, and distributes medicines and supplies for the public health system, and it structures tenders into international and local categories, with the local category reserved for Zambian-based manufacturers. ZAMMSA does not buy production machinery. Its award pattern decides which local plant can underwrite the next line, so its tender calendar is a leading indicator for equipment enquiries.

How pharma equipment deals get paid

The 2026 payment picture is friendlier than the historical one, and the difference matters at quote stage.

The kwacha floats, and it has been appreciating. After an all-time weak point near 29 per dollar in March 2025, the currency strengthened to roughly 19 per dollar by August 2026, a multi-year high, with the Bank of Zambia policy rate at 13.25 percent as of the May 2026 decision. Zambia’s debt restructuring is substantially complete after the IMF’s final programme review in January 2026. Quote in USD or EUR, date any rate assumption, and remember that historic kwacha volatility is why Zambian finance directors still stress-test the FX line in every capex approval.

Letters of credit run through Zanaco, Stanbic Zambia, Absa Zambia, and FNB Zambia, with foreign-issued LCs commonly confirmed offshore. Export credit cover follows the equipment’s origin: SACE or Euler Hermes on Italian and German sterile-processing scope, UKEF on British kit, Sinosure on Chinese utility and packaging machinery. All tender and contract documentation is in English, Zambia’s sole official language.

The MFEZ waiver is the single most valuable line in a Zambian pharma quote. Qualifying machinery imported into a Multi-Facility Economic Zone enters free of customs duty, excise, and VAT, and the Akums plant is being built inside one, with the Lusaka South MFEZ operator listing NRB Pharma among its tenants too. Outside the zones, the ZRA regime applies: duty bands up to 25 percent and VAT at 16 percent, processed through ASYCUDA World. Confirm the exact tariff line with ZRA before quoting delivered cost, and confirm the buyer’s zone status first, because it can move the landed price by double digits.

Milestone structures on greenfield scope track qualification. Expect an advance against bank guarantee, the main tranche against shipping documents under LC, and a final portion held to installation and performance qualification sign-off. On a plant that must pass ZAMRA GMP licensing before its offtake contract activates, buyers have every incentive to hold that tail firmly. Price it, and staff the qualification support to release it early.

Integrators, and why there is no EPC to hide behind

Zambia has no standing pharmaceutical EPC contractor, and the anchor project imports its own. Akums brings its Indian engineering organisation to the Lusaka build, so component and utility vendors sell into that project team rather than waiting for a local main contractor’s enquiry. For the existing producers, process machinery is bought directly from the OEM, while civils and cleanroom fit-out go to Lusaka industrial contractors or South African specialist firms under separate appointments.

The practical consequence: the vendor’s counterpart is the plant owner’s project engineer or the Indian project office, and validation consultants are allies who influence specifications. A supplier waiting for a published EPC package will see almost none of this market. The selling motion is direct, early, and technical.

Tender platforms and procurement entry points

Public-side procurement runs through one mandatory system. The ZPPA e-GP portal is compulsory for Zambian public procurement, with ZPPA Circular No. 37 of 2025 governing the limited cases allowed outside it. Foreign suppliers register once on e-GP and filter by category. This is where ZAMMSA supply tenders, Ministry of Health laboratory and cold-chain packages, and public university equipment purchases surface.

Private and JV equipment purchases never appear there. They surface through the ZAMRA site-licensing pipeline, which functions as Zambia’s closest thing to a published list of upcoming plant projects, through the Lusaka South MFEZ operator and the Zambia Development Agency, and through direct contact with the named plants. For the wider machinery of Zambian tendering, bonds, and bank guarantees across all sectors, see our Zambia industrial procurement guide.

Two timing notes. Zambia held general elections in August 2026, and public tender activity around an election cycle tends to bunch before and after it, so build slack into ZAMMSA-linked timelines. And Zambia is landlocked: heavy equipment lands at Dar es Salaam or Durban and moves by road on the TAZARA corridor or the North-South Corridor, so sequence cleanroom panels and oversized skids against realistic inland transit times rather than the port arrival date.

The conventional channels, and what they miss

The old route into this market was a booth, a distributor, or a resident rep. Each one now covers less of the buying than it used to.

The Zambia International Trade Fair in Ndola is the country’s flagship exhibition, and it is a general industrial and consumer show. The pharma decision-makers who sign equipment orders are a handful of production directors and one project office, and they are more reliably found at WHX Johannesburg, formerly Africa Health, running 6 to 8 October 2026 at Gallagher Convention Centre, or at Propak Africa in Johannesburg for the packaging tier. South Africa hosts the shows because South Africa supplies about 29 percent of Zambia’s imports. A booth there reaches Zambian buyers one week a year, alongside every competitor, at a cost that resets to zero when the hall closes.

Field representation has the same arithmetic in a thinner market. A Johannesburg- or Nairobi-based rep covers Zambia occasionally, works the two or three accounts already known, and never reaches the plant that has not yet announced itself through a ZAMRA application.

Distributor lock-in is the structural issue. Zambian medicine and laboratory supply flows through established Lusaka importer-distributors, next to the South African, Indian, and Chinese channels that already carry the consumables trade. Those relationships move stock efficiently and sell capital equipment badly: the OEM becomes a catalogue line behind a margin, absent from the specification conversation where machines are actually chosen.

Systematic outbound into the named Zambian buyer set runs USD 150 to 300 per qualified lead and compounds as account intelligence accumulates. The booth and the rep are linear costs against a buyer list this concentrated. On a market of one anchor project and seven producers, precision beats presence.

FAQ

Do equipment suppliers need a ZAMRA licence to sell into Zambia?

No. ZAMRA licenses manufacturing sites and authorises medicines, not machinery vendors. What ZAMRA’s GMP regime does demand from you is documentation: qualification protocols, material certificates, and calibration records that let your buyer pass inspection. Vendors who ship strong validation packs win repeat Zambian orders on that strength alone.

What import charges apply to pharmaceutical machinery entering Zambia?

Inside a Multi-Facility Economic Zone, qualifying equipment enters free of customs duty, excise, and VAT. Outside the zones, ZRA duty bands run up to 25 percent with VAT at 16 percent. Always confirm the buyer’s zone status and the exact tariff classification with ZRA before quoting a delivered price.

How does a vendor get in front of the Akums Lusaka project?

Equipment decisions sit with the Akums project organisation driving the Lusaka South MFEZ build, not on any public portal. Direct engagement with the project engineering team, referenced installations in Africa or India, and readiness on beta-lactam segregation scope are the entry ticket. Confirm the current vendor process with the project office before quoting.

Is there equipment business in Zambia beyond the Akums build?

Yes, though it is smaller and steadier. Pharmanova runs three Lusaka sites, and NRB Pharma, International Drug Company, and Yashi Life Sciences all face GMP upgrade pressure from ZAMRA inspections. ZAMMSA’s local-preference tender categories give these producers a demand base that justifies line extensions, packaging upgrades, and utility improvements.

Where to go next

For equipment-level depth, see our Zambia guides on tablet press suppliers, injectable filling lines, cleanroom HVAC suppliers, and the blister packaging machine project guide. For banking, customs, and tender mechanics across every Zambian sector, start from the Zambia industrial procurement guide.

If you want your product category mapped against the Zambian pharmaceutical buyer set, plant by plant, get in touch or write to burak@papaverai.com and we will tell you which of these projects is actually buying this year.